Biolife Solutions (BLFS) Common Equity (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Common Equity of $372.2 million for Q1 2026, up 5.56% year-over-year from $352.6 million in Q1 2025, and little changed quarter-over-quarter from $371.9 million in Q4 2025.
Biolife Solutions (BLFS) Common Equity (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Common Equity for 17 consecutive years, with $372.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity rose 5.56% year-over-year to $372.2 million; the TTM figure through Mar 2026 stood at $372.2 million (up 5.56% YoY), while the FY2025 annual figure was $371.9 million, up 6.59% from the prior year.
- Common Equity was little changed at $372.2 million in Q1 2026 per BLFS's latest filing, from $371.9 million in the prior quarter.
- Across five years, Common Equity topped out at $476.1 million in Q1 2022 and bottomed at $321.4 million in Q2 2024.
- Historically, Common Equity has averaged $362.5 million across 5 years, with a median of $352.6 million in 2025.
- Annual changes were most pronounced in 2022 — Common Equity surged 128.03% — and 2023, when it fell 24.78%.
- Biolife Solutions' Common Equity stood at $364.2 million in 2022, then fell by 7.28% to $337.7 million in 2023, then climbed by 3.33% to $348.9 million in 2024, then grew by 6.59% to $371.9 million in 2025, then advanced by 0.09% to $372.2 million in 2026.
- Business Quant data shows BLFS's Common Equity at $372.2 million in Q1 2026, $371.9 million in Q4 2025, and $353.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.84 Bn | 129.62 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 52.51 Bn | 51.64 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.73 Bn | 34.37 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.92 Bn | 32.45 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 29.13 Bn | 26.46 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 24.89 Bn | 24.45 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Biolife Solutions | 1.81 Bn | 1.73 Bn | 18.29 Mn | 420.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 420.00 Mn |
| Mar 31, 2026 | 372.23 Mn |
| Dec 31, 2025 | 371.89 Mn |
| Sep 30, 2025 | 353.74 Mn |
| Jun 30, 2025 | 347.16 Mn |
| Mar 31, 2025 | 352.62 Mn |
| Dec 31, 2024 | 348.91 Mn |
| Sep 30, 2024 | 325.46 Mn |
| Jun 30, 2024 | 321.44 Mn |
| Mar 31, 2024 | 333.41 Mn |
| Dec 31, 2023 | 337.66 Mn |
| Sep 30, 2023 | 332.02 Mn |
| Jun 30, 2023 | 352.13 Mn |
| Mar 31, 2023 | 358.11 Mn |
| Dec 31, 2022 | 364.19 Mn |
| Sep 30, 2022 | 405.12 Mn |
| Jun 30, 2022 | 409.54 Mn |
| Mar 31, 2022 | 476.08 Mn |
| Dec 31, 2021 | 478.05 Mn |
| Sep 30, 2021 | 489.26 Mn |